Publications:
Our Research

Filter

Filter

Research Area
Technology
Resource type
Category
218 results found
Nov 25, 2020
Publication
Novavax led
Vaccine
COVID-19, Matrix-M® adjuvant
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
Guebre-Xabier M, Patel N, Tian JH, et al.
Nov 4, 2020
Publication
Novavax led
Clinical Infectious Diseases
Seasonal influenza, Matrix-M® adjuvant
Induction of Cross-reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine
Shinde, Vivek, Cai, Rongman, Plested, Joyce S., et al.
Oct 30, 2020
Presentation
COVID-19
NVX-CoV2373 Vaccine Candidate

Meeting Of The Advisory Committee On Immunization Practices (ACIP)

Dubovsky, Filip
Oct 20, 2020
Publication
Collaborative
Science Magazine
COVID-19
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
Bangaru, Sandhya, Ozorowski, Gabriel, Turner, Hannah L., et al.
Oct 20, 2020
Presentation
COVID-19
Recombinant Nanoparticle COVID-19 Vaccine: Platform Technology for Emerging Infectious Diseases (EID)

2020 World Vaccine Congress Europe

Glenn, Gregory
Oct 14, 2020
Publication
Novavax led
Vaccine
RSV
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity
Patel, Nita , Tian, Jing-Hui, Flores, Rhonda, et al.
Oct 7, 2020
Publication
Novavax led
Vaccine
Seasonal influenza
Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance
Bruce-Staskal, Pamela J., Woods, Robert M., Borisov, Oleg V. , et al.
Oct 1, 2020
Presentation
Seasonal influenza
NanoFlu™ Vaccine Update: Phase 3 ResultsVivek Shinde, MD, MPH, VP Clinical Development October 1st, 2020
Shinde, Vivek
Oct 1, 2020
Presentation
RSV
Phase 3 and Beyond: Maternal RSV & Older Adult Influence Vaccine Program

World Vaccine Congress Washington 2020

Glenn, Gregory
Sep 28, 2020
Presentation
COVID-19
Recombinant nanoparticle COVID-19 vaccine: Platform technology for EID (Emerging Infectious Diseases)

World Vaccine Congress Washington 2020

Glenn, Gregory